Switzerland · Delayed Price · Currency is CHF Novartis AG Statistics
Total Valuation
Novartis AG has a market cap or net worth of CHF 221.81 billion. The enterprise value is 239.97 billion.
| Market Cap | 221.81B |
| Enterprise Value | 239.97B |
Important Dates
The next estimated earnings date is Wednesday, February 4, 2026.
| Earnings Date | Feb 4, 2026 |
| Ex-Dividend Date | Mar 11, 2025 |
Share Statistics
Novartis AG has 1.92 billion shares outstanding. The number of shares has decreased by -3.84% in one year.
| Current Share Class | 1.92B |
| Shares Outstanding | 1.92B |
| Shares Change (YoY) | -3.84% |
| Shares Change (QoQ) | -1.02% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 36.92% |
| Float | 1.83B |
Valuation Ratios
The trailing PE ratio is 19.86 and the forward PE ratio is 16.44. Novartis AG's PEG ratio is 2.06.
| PE Ratio | 19.86 |
| Forward PE | 16.44 |
| PS Ratio | 4.93 |
| PB Ratio | 6.22 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.21 |
| P/OCF Ratio | 13.20 |
| PEG Ratio | 2.06 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.95, with an EV/FCF ratio of 15.37.
| EV / Earnings | 20.91 |
| EV / Sales | 5.34 |
| EV / EBITDA | 11.95 |
| EV / EBIT | 14.72 |
| EV / FCF | 15.37 |
Financial Position
The company has a current ratio of 0.88, with a Debt / Equity ratio of 0.72.
| Current Ratio | 0.88 |
| Quick Ratio | 0.58 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | 1.27 |
| Debt / FCF | 1.64 |
| Interest Coverage | 18.35 |
Financial Efficiency
Return on equity (ROE) is 32.62% and return on invested capital (ROIC) is 16.78%.
| Return on Equity (ROE) | 32.62% |
| Return on Assets (ROA) | 12.13% |
| Return on Invested Capital (ROIC) | 16.78% |
| Return on Capital Employed (ROCE) | 27.17% |
| Revenue Per Employee | 592,358 |
| Profits Per Employee | 151,242 |
| Employee Count | 75,883 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.17 |
Taxes
In the past 12 months, Novartis AG has paid 1.62 billion in taxes.
| Income Tax | 1.62B |
| Effective Tax Rate | 12.40% |
Stock Price Statistics
The stock price has increased by +29.09% in the last 52 weeks. The beta is 0.45, so Novartis AG's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +29.09% |
| 50-Day Moving Average | 107.05 |
| 200-Day Moving Average | 99.41 |
| Relative Strength Index (RSI) | 68.92 |
| Average Volume (20 Days) | 3,078,104 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novartis AG had revenue of CHF 44.95 billion and earned 11.48 billion in profits. Earnings per share was 5.82.
| Revenue | 44.95B |
| Gross Profit | 34.27B |
| Operating Income | 16.31B |
| Pretax Income | 13.09B |
| Net Income | 11.48B |
| EBITDA | 19.87B |
| EBIT | 16.31B |
| Earnings Per Share (EPS) | 5.82 |
Balance Sheet
The company has 7.71 billion in cash and 25.53 billion in debt, with a net cash position of -17.82 billion or -9.29 per share.
| Cash & Cash Equivalents | 7.71B |
| Total Debt | 25.53B |
| Net Cash | -17.82B |
| Net Cash Per Share | -9.29 |
| Equity (Book Value) | 35.68B |
| Book Value Per Share | 18.42 |
| Working Capital | -3.03B |
Cash Flow
In the last 12 months, operating cash flow was 16.80 billion and capital expenditures -1.19 billion, giving a free cash flow of 15.61 billion.
| Operating Cash Flow | 16.80B |
| Capital Expenditures | -1.19B |
| Free Cash Flow | 15.61B |
| FCF Per Share | 8.14 |
Margins
Gross margin is 76.25%, with operating and profit margins of 36.29% and 25.53%.
| Gross Margin | 76.25% |
| Operating Margin | 36.29% |
| Pretax Margin | 29.13% |
| Profit Margin | 25.53% |
| EBITDA Margin | 44.21% |
| EBIT Margin | 36.29% |
| FCF Margin | 34.73% |
Dividends & Yields
This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 3.03%.
| Dividend Per Share | 3.50 |
| Dividend Yield | 3.03% |
| Dividend Growth (YoY) | 6.06% |
| Years of Dividend Growth | 29 |
| Payout Ratio | 54.32% |
| Buyback Yield | 3.84% |
| Shareholder Yield | 6.87% |
| Earnings Yield | 5.17% |
| FCF Yield | 7.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 7, 2001. It was a forward split with a ratio of 40.
| Last Split Date | May 7, 2001 |
| Split Type | Forward |
| Split Ratio | 40 |
Scores
Novartis AG has an Altman Z-Score of 3.8 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.8 |
| Piotroski F-Score | 7 |